In vivo, we demonstrate that LMO3 preserves a metabolically beneficial visceral adipose tissue expansion and insulin sensitivity along with enhanced adiponectin secretion during obesity. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.